We provide evidence in this report that estrogen treatment leads to enhanced levels of VEGF secretion by thyroid cancer cells, thus leading to enhanced angiogenesis associated events, including migration, proliferation and tubulogenesis of endothelial cells cultured in presence of thyroid cancer cell conditioned medium. This evidence concerns the gene VEGFA and thyroid gland carcinoma.